Weekly Gene
|
【Gene of the Week】Popular Gene Target of Lung Cancer Research – MET |
Jul 28, 2021 |
The MET (Mesenchymal Epithelial Transition) gene encodes a prototypical receptor tyrosine kinase, which is involved in the tyrosine kinase signaling pathway that regulates cell motility, survival, proliferation, invasion, and metastasis in many cancers. Read More > |
Newsletter
|
FAQ: Cell Line Generation Basics |
Jul 27, 2021 |
It is well known that cell lines play an important role in gene function studies, drug screening, and the production of recombinant proteins and antibodies. Herein, we have collected the Frequently Asked Questions on cell line generation, hoping to help researchers gain a proper understanding of how cell lines are developed and used. Read More > |
Newsletter
|
How to Find the Best Immunodeficient Mice Model for Your Research? |
Jul 27, 2021 |
The lack of appropriate animal models often limits the study of human pathologies. Infectious diseases in humans are primarily studied using mice. However, many human-specific infectious agents do not affect mice. Immune-deficient laboratory mice are genetically engineered to express human genes or transplanted with human tissues or stem cells. Human genes, organs, pathologies, and drugs intended for human use can be studied using these mice. Read More > |
Newsletter
|
Comprehensive Introduction of Apoe Knockout Mice |
Jul 02, 2021 |
Apoe knockout mice can be used to study the function of APOE in lipid metabolism, atherosclerosis, and nerve damage; It also helps to study interventional therapies that can change the atherosclerotic process. Read More > |
Weekly Gene
|
[Gene of The Week] FGF21: Metabolic Disease Related Gene |
Jul 02, 2021 |
FGF21 gene plays a significant role in the pathogenesis of metabolic diseases such as non-alcoholic fatty liver, obesity and insulin resistance. Read More > |
Weekly Gene
|
【Gene of the Week】DMD: Duchenne Muscular Dystrophy Pathogenic Gene |
Jul 02, 2021 |
Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration. It usually starts in early childhood. Read More > |
Newsletter
|
Examples of Gene Therapy Treatments for Rare Diseases |
Jun 18, 2021 |
This article will introduce the current research progress and case analysis of gene therapies for rare diseases. Read More > |
Newsletter
CGT
|
What are the Strategies for Gene Therapy? |
Jun 18, 2021 |
Gene therapy refers to the introduction of exogenous (normal) genes into target cells to correct or compensate for the diseases caused by defects and abnormal genes, to achieve the purpose of disease treatment. Read More > |
Newsletter
|
What is Gene Therapy? An Introduction to the Research |
Jun 18, 2021 |
Gene therapy is designed to treat diseases by introducing exogenous DNA or RNA into human target cells, which may be achieved by a few different methods. Read More > |
Newsletter
KO cell
|
What are Knockout Cell Lines Used For? |
Jun 17, 2021 |
As an easy-to-use and powerful gene-editing tool, CRISPR-Pro has been widely used in applications ranging from basic research to the treatment of genetic diseases. The development of this technology has made the generation of knockout (KO) cell line models more accessible. Why use knockout cell lines? In this article, we review the various applications of the knockout cell lines, hoping to bring some inspiration for your research. Read More > |